Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Aníbal García‐Sempere

Datos Biográficos

ID6775244
NOMBREAníbal García‐Sempere
NOMBRESAníbal
APELLIDOGarcía‐Sempere
FIRMASEMPERE A G
AFILIACIONESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
ORCID0000-0002-4313-3976
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2019
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity

    Open Access•Celia Robles Cabanillas, Isabel Hurtado et al.•ARTICLE•Gaceta Sanitaria•2025

    To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…

  • Seroprevalence of antibodies against Sars-CoV-2 in the Valencian Community (Spain) as of October 2022

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Gaceta Sanitaria•2023

    To estimate the seroprevalence of SARS-CoV-2 antibodies in the Valencian Community (Spain) in October 2022, when BA.5 was the predominant variant. Cross-sectional, region-wide, population-based serosurvey study in 88 randomly selected primary care centers of the Valencian Community. Seroprevalence of anti-nucleocapsid (indicative of past infection) and total receptor binding domain (indicative of past infection or vaccination) antibodies was 71.0…

  • Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Medical Care•2020•Referencias: 17

    BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…

  • Building learning health systems on Real World Data

    Open Access•Enrique Bernal‐Delgado, Aníbal García‐Sempere et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

Sin obras prominentes en esta página.

  • Building learning health systems on Real World Data

    Open Access•Enrique Bernal‐Delgado, Aníbal García‐Sempere et al.•ARTICLE•International Journal of…•2019

    The International Journal of Integrated Care (IJIC) is an online, open-access, peer-reviewed scientific journal that publishes original articles in the field of integrated care on a continuous basis.IJIC has an Impact Factor of 5.120 (2020 JCR, received in June 2021)

  • Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Medical Care•2020•Referencias: 17

    BACKGROUND: The Time in Therapeutic Range (TTR) is the gold-standard measure used to assess the quality of oral anticoagulation with vitamin K antagonists. However, TTR is a static measure, and International Normalized Ratio (INR) control is a dynamic process. Group-based Trajectory Models (GBTM) can address this dynamic nature by classifying patients into different trajectories of INR control over time. OBJECTIVES: The objective of this study wa…

  • Seroprevalence of antibodies against Sars-CoV-2 in the Valencian Community (Spain) as of October 2022

    Open Access•Aníbal García-Sempere, Aníbal García‐Sempere et al.•ARTICLE•Gaceta Sanitaria•2023

    To estimate the seroprevalence of SARS-CoV-2 antibodies in the Valencian Community (Spain) in October 2022, when BA.5 was the predominant variant. Cross-sectional, region-wide, population-based serosurvey study in 88 randomly selected primary care centers of the Valencian Community. Seroprevalence of anti-nucleocapsid (indicative of past infection) and total receptor binding domain (indicative of past infection or vaccination) antibodies was 71.0…

  • Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity

    Open Access•Celia Robles Cabanillas, Isabel Hurtado et al.•ARTICLE•Gaceta Sanitaria•2025

    To evaluate the risk of acute pancreatitis and biliary disease in patients treated with glucagon-like peptide-1 receptor agonists (GLP-1 RA). Population-based, propensity-weighted, new user, active comparator design study including patients with diabetes and obesity initiating treatment with GLP-1 RA or the comparator group sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in the region of Valencia from 2015 to 2021. In adjusted, per protocol m…

Medicine (3 obras) · Computer Science (2 obras) · Environmental health (2 obras) · Population (2 obras) · Acute pancreatitis (1 obras) · Agonist (1 obras) · Antibody (1 obras) · Artificial Intelligence (1 obras) · Artificial Intelligence (1 obras) · Artificial Intelligence in Healthcare (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae